tiprankstipranks
Peak Bio Announces CEO Transition and New Leadership
Company Announcements

Peak Bio Announces CEO Transition and New Leadership

Don't Miss our Black Friday Offers:

An update from Peak Bio (PKBO) is now available.

Stephen LaMond has stepped down as the Interim CEO and COO of Peak Bio, Inc., and will transition to a consulting role to aid in handing over to new management. His departure is coupled with a separation agreement that includes a consulting fee and stock options, while Hoyoung Huh will take over CEO duties effective immediately. LaMond’s agreement includes financial compensation and benefits, ensuring a smooth management transition.

For an in-depth examination of PKBO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPeak Bio Merges with Akari, Restructures Leadership
TheFlyAkari Therapeutics announce shareholder approval connected with Peak Bio merger
TheFlyAkari Therapeutics announces effectiveness of Form S-4 related to merger
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App